Active investors might be tracking Return on Invested Capital (ROIC) information on Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). ROIC is a metric that can be used to assess the efficiency of a particular company at allocating controlled capital into investments that are profitable. ROIC can provide a good sense of how a company is using its money to generate returns. ROIC may provide the clearest picture of just how efficient a company is at using its capital. Momenta Pharmaceuticals, Inc. presently has an ROIC of -1.017926. The current ROIC 5 year average is -0.08172 and the ROIC Quality ratio is currently -0.159109.
Checking on another financial indicator, Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) has an EV (Enterprise Value) of 840865. EV represents the complete economic value of a given company. EV is considered to measure the theoretical takeover price if a company was to be acquired. EV takes into account more than just the outstanding equity. Debt and cash can have a big impact on a firm’s Enterprise Value. Although two companies may have a similar market cap, they may have widely different EV values.
Value Investors may be looking to track the Magic Formula Rank or MF Rank for Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). After a recent check, Momenta Pharmaceuticals, Inc. has a MF Rank of 14399. The Magic Formula was developed by Joel Greenblatt in his publication “The Little Book That Beats the Market”. Greenblatt’s formula helps spot stocks that are priced attractively with a high earnings yield, or solid reported profits compared to the market value of the company. To identify opportunities in the equity market, investors may be checking for stocks that have the lowest combined MF Rank.
Individual investors are often tracking multiple metrics in an attempt to maximize profits. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) currently has a Gross Margin (Marx) ratio of 0.06639. Robert Novy-Marx has provided investors with insights on finding high-quality value stocks. Marx pointed to a high gross income ratio defining the quality of a company. Momenta Pharmaceuticals, Inc. has a Gross Margin score of 63. The Gross Margin score lands between 1 and 100 where a score of 1 would be seen as good, and a score of 100 would be considered bad. This score is based on the Gross Margin stability and growth over the previous 8 years.
Equity investors are always trying to find the next great stock pick. Uncovering the next winner to stuff the portfolio may entail very hard work and market dedication. Analyzing the vast sea of information about public companies can be a daunting task. Many sharp investors will approach the equity markets from multiple angles. This may include keeping close tabs on fundamental and technical data. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) has a present Value Composite Score of 87. This score lands on a scale from 0 to 100 where a lower score would indicate an undervalued company and a higher score would indicate an overvalued company. This ranking was created by James O’Shaughnessy using six different valuation ratios including price to book value, price to sales, EBITDA to EV, price to cash flow, price to earnings, and shareholder yield.